Asthma; Chronic hepatitis B; Inflammatory bowel disease

Ten Year TARGET-ASTHMA Study Using Data for New Therapies and to Develop New Drugs

Post author:Rose Duesterwald
Post published:March 30, 2020
Post category:Rare Disease

TARGET PharmaSolutions Inc. recently announced enrollment of the first patients in its ten year, ten thousand patient asthma study. Professor Michael Wechsler, M.D. pulmonologist at the National Jewish Health organization…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More